Skip to main content
. 2012 Nov 28;7(11):e50513. doi: 10.1371/journal.pone.0050513

Figure 4. Fasting VLDL lipolysis products attenuate LPS-induced TNFα release.

Figure 4

(A-B) Monocytes treated with fasting or postprandial VLDL lipolysis products and LPS exhibited dose-dependent attenuation of TNFα secretion (n = 6). A: fasting VLDL; B: postprandial VLDL. *P<0.01 from control, #P<0.05 from the same concentration dose without LpL. (C) Postprandial remnants (VLDL rem) attenuate LPS-induced TNFα secretion more than fasting remnants. *P<0.05 from control, #P<0.05 from fasting.